281 related articles for article (PubMed ID: 12436296)
21. Classification of Ph-negative chronic myeloproliferative disorders--morphology as the yardstick of classification.
Kvasnicka HM; Thiele J
Pathobiology; 2007; 74(2):63-71. PubMed ID: 17587877
[TBL] [Abstract][Full Text] [Related]
22. Myelofibrosis in chronic myeloproliferative disorders. Incidence among subtypes according to the Hannover Classification.
Buhr T; Georgii A; Choritz H
Pathol Res Pract; 1993 Mar; 189(2):121-32. PubMed ID: 8321741
[TBL] [Abstract][Full Text] [Related]
23. Acute myelofibrosis.
Das S; Prabhakar BR
Indian J Pathol Microbiol; 1997 Oct; 40(4):527-30. PubMed ID: 9444866
[TBL] [Abstract][Full Text] [Related]
24. [Clinical characteristics of primary myelofibrosis].
Simeonov Ts; Petrov I
Vutr Boles; 1979; 18(6):108-12. PubMed ID: 524867
[TBL] [Abstract][Full Text] [Related]
25. Acute panmyelosis with myelofibrosis: a clinicopathological study on 46 patients including histochemistry of bone marrow biopsies and follow-up.
Thiele J; Kvasnicka HM; Zerhusen G; Vardiman J; Diehl V; Luebbert M; Schmitt-Graeff A
Ann Hematol; 2004 Aug; 83(8):513-21. PubMed ID: 15173958
[TBL] [Abstract][Full Text] [Related]
26. Diagnosis and quantification of bone marrow fibrosis are significantly biased by the pre-staining processing of bone marrow biopsies.
Buesche G; Georgii A; Kreipe HH
Histopathology; 2006 Jan; 48(2):133-48. PubMed ID: 16405662
[TBL] [Abstract][Full Text] [Related]
27. Essential thrombocythemia or chronic idiopathic myelofibrosis? A single-center study based on hematopoietic bone marrow histology.
Gianelli U; Vener C; Raviele PR; Moro A; Savi F; Annaloro C; Somalvico F; Radaelli F; Franco V; Deliliers GL
Leuk Lymphoma; 2006 Sep; 47(9):1774-81. PubMed ID: 17064987
[TBL] [Abstract][Full Text] [Related]
28. Platelet-derived growth factor receptor β (PDGFRβ) immunohistochemistry highlights activated bone marrow stroma and is potentially predictive for fibrosis progression in prefibrotic myeloproliferative neoplasia.
Méhes G; Tzankov A; Hebeda K; Anagnostopoulos I; Krenács L; Bedekovics J
Histopathology; 2015 Nov; 67(5):617-24. PubMed ID: 25825163
[TBL] [Abstract][Full Text] [Related]
29. [Prognostic value of bone marrow biopsy in chronic myeloproliferative disorders].
Bettini R; Marzetta K; Miglioranza A; Redaelli S; Maino C; Maffiolini A; Gorini M
Recenti Prog Med; 2003; 94(7-8):314-20. PubMed ID: 12868237
[TBL] [Abstract][Full Text] [Related]
30. Aberrant collagenase expression in chronic idiopathic myelofibrosis is related to the stage of disease but not to the JAK2 mutation status.
Bock O; Neuse J; Hussein K; Brakensiek K; Buesche G; Buhr T; Wiese B; Kreipe H
Am J Pathol; 2006 Aug; 169(2):471-81. PubMed ID: 16877349
[TBL] [Abstract][Full Text] [Related]
31. [Relation of acute myelofibrosis and megakaryoblastic leukemia. Immunohistochemical observations on bone marrow biopsies].
Pich A; Navone R; Azzoni L
Recenti Prog Med; 1988 Dec; 79(12):487-92. PubMed ID: 3241898
[No Abstract] [Full Text] [Related]
32. Initial (prefibrotic) stages of idiopathic (primary) myelofibrosis (IMF) - a clinicopathological study.
Thiele J; Kvasnicka HM; Boeltken B; Zankovich R; Diehl V; Fischer R
Leukemia; 1999 Nov; 13(11):1741-8. PubMed ID: 10557047
[TBL] [Abstract][Full Text] [Related]
33. Chronic idiopathic myelofibrosis: clinicopathologic features, pathogenesis, and prognosis.
Ahmed A; Chang CC
Arch Pathol Lab Med; 2006 Aug; 130(8):1133-43. PubMed ID: 16879014
[TBL] [Abstract][Full Text] [Related]
34. Myelofibrosis secondary to hyperparathyroidism.
Kumbasar B; Taylan I; Kazancioglu R; Agan M; Yenigun M; Sar F
Exp Clin Endocrinol Diabetes; 2004 Mar; 112(3):127-30. PubMed ID: 15052531
[TBL] [Abstract][Full Text] [Related]
35. [Quantitative study of the medullar fibrosis in 84 cases of idiopathic myeloid splenomegaly (author's transl)].
Dumont J; d'Athis P; Atken N; Binet JL; Ripault J; Worhauer W; Bernard J
Pathol Biol (Paris); 1979 Apr; 27(4):221-6. PubMed ID: 379761
[TBL] [Abstract][Full Text] [Related]
36. Dynamics of fibrosis in chronic idiopathic (primary) myelofibrosis during therapy: a follow-up study on 309 patients.
Thiele J; Kvasnicka HM; Schmitt-Graeff A; Diehl V
Leuk Lymphoma; 2003 Jun; 44(6):949-53. PubMed ID: 12854892
[TBL] [Abstract][Full Text] [Related]
37. Unusual presentation of myelofibrosis.
Naina HV; Harris S
Intern Med J; 2008 Jan; 38(1):70-1. PubMed ID: 18190422
[No Abstract] [Full Text] [Related]
38. The diagnostic utility of bone marrow trephine biopsies.
Sitalakshmi S; Srikrishna A; Devi S; Damodar P; Alexander B
Indian J Pathol Microbiol; 2005 Apr; 48(2):173-6. PubMed ID: 16758657
[TBL] [Abstract][Full Text] [Related]
39. Myelofibrosis--what's in a name? Consensus on definition and EUMNET grading.
Thiele J; Kvasnicka HM
Pathobiology; 2007; 74(2):89-96. PubMed ID: 17587880
[TBL] [Abstract][Full Text] [Related]
40. Myelofibrosis with myeloid metaplasia: the advanced phase of an untreated disseminated hematological cancer. Time to change our therapeutic attitude with early upfront treatment?
Hasselbalch HC
Leuk Res; 2009 Jan; 33(1):11-8. PubMed ID: 18632152
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
